Pliant Therapeutics (PLRX) PT Raised to $40 at Piper Sandler
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.08 -5.26%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Piper Sandler analyst Tyler Van Buren raised the price target on Pliant Therapeutics (NASDAQ: PLRX) to $40.00 (from $27.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- AMD (AMD) PT Raised to $720 at BofA Securities
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR4,665 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
